Literature DB >> 24492767

New horizons for cancer gene therapy.

S K Libutti.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24492767     DOI： 10.1038/cgt.2013.80

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN： 0929-1903            Impact factor:   5.987


× No keyword cloud information.
  6 in total

1.  A pilot feasibility study of TNFerade™ biologic with capecitabine and radiation therapy followed by surgical resection for the treatment of rectal cancer.

Authors:  Deborah Citrin; Kevin Camphausen; Bradford J Wood; Martha Quezado; John Denobile; James F Pingpank; Richard E Royal; H Richard Alexander; Geoffrey Seidel; Seth M Steinberg; Yvonne Shuttack; Steven K Libutti
Journal:  Oncology       Date:  2011-03-25       Impact factor: 2.935

2.  Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.

Authors:  J Zhao; J Jin; X Zhang; M Shi; J Dai; M Wu; R Wang; Y Guo
Journal:  Cancer Gene Ther       Date:  2006-04       Impact factor: 5.987

Review 3.  Gene-engineered T cells for cancer therapy.

Authors:  Michael H Kershaw; Jennifer A Westwood; Phillip K Darcy
Journal:  Nat Rev Cancer       Date:  2013-08       Impact factor: 60.716

4.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

5.  Additive antileukemia effects by GFI1B- and BCR-ABL-specific siRNA in advanced phase chronic myeloid leukemic cells.

Authors:  M Koldehoff; J L Zakrzewski; D W Beelen; A H Elmaagacli
Journal:  Cancer Gene Ther       Date:  2013-06-21       Impact factor: 5.987

6.  Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity.

Authors:  Z Yuan; G Syrkin; A Adem; R Geha; J Pastoriza; C Vrikshajanani; T Smith; T J Quinn; G Alemu; H Cho; C J Barrett; W Arap; R Pasqualini; S K Libutti
Journal:  Cancer Gene Ther       Date:  2012-11-16       Impact factor: 5.987
  6 in total
  3 in total

1.  Folate-conjugated polyspermine for lung cancer-targeted gene therapy.

Authors:  Mei Zhang; You-Kyoung Kim; Pengfei Cui; Jialiang Zhang; Jianbin Qiao; Yujing He; Jinyuan Lyu; Chengqiong Luo; Lei Xing; Hulin Jiang
Journal:  Acta Pharm Sin B       Date:  2016-04-12       Impact factor: 11.413

2.  Preparation, characterization, and transfection efficiency of low molecular weight polyethylenimine-based nanoparticles for delivery of the plasmid encoding CD200 gene.

Authors:  Fatemeh Nouri; Hossein Sadeghpour; Reza Heidari; Ali Dehshahri
Journal:  Int J Nanomedicine       Date:  2017-08-03

3.  Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.

Authors:  Ling Ye; Yuan Yang; Xin-Yu Ma; Dan Li; Mei-Li Xu; Pan Tan; Li-Min Long; Hai-Qin Wang; Ting Liu; Yong-Hong Guo
Journal:  Exp Ther Med       Date:  2017-09-20       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.